Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
77 JPY | 0.00% | -1.28% | -37.90% |
Apr. 15 | Modalis Therapeutics to See Reduced Expenses of 250 to 350 Million After Cutting Jobs | MT |
Feb. 23 | Modalis Therapeutics to Reduce Stated Capital and Capital Reserves | MT |
Chart calendar Modalis Therapeutics Corporation
Upcoming events on Modalis Therapeutics Corporation
Past events on Modalis Therapeutics Corporation
2024-02-19 | Q4 2023 Earnings Call |
2024-02-13 | Q4 2023 Earnings Release |
2023-11-06 | Q3 2023 Earnings Release |
2023-08-06 | Q2 2023 Earnings Release |
2023-05-19 01:45 pm | American Society of Gene Cell Therapy Meeting |
2023-05-08 | Q1 2023 Earnings Release |
2023-02-12 | FY 2022 Earnings Release |
2022-11-06 | Q3 2022 Earnings Release |
2022-08-04 | Interim 2022 Earnings Release |
2022-05-18 05:30 pm | American Society of Gene and Cell Therapy Conference - Neurologic Diseases III/W-153 |
2022-05-18 10:30 am | American Society of Gene and Cell Therapy Conference |
2022-05-17 05:30 pm | American Society of Gene and Cell Therapy Conference |
2022-05-16 05:30 pm | American Society of Gene and Cell Therapy Conference |
2022-05-16 11:45 am | American Society of Gene and Cell Therapy Conference |
2022-05-08 | Q1 2022 Earnings Release |
2022-02-13 | FY 2021 Earnings Release |
2021-11-04 | Q3 2021 Earnings Release |
2021-08-04 | Interim 2021 Earnings Release |
2021-05-05 | Q1 2021 Earnings Release |
2021-03-29 09:00 pm | Shareholdersl Meeting |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 342 341 0.29% | 1,00 2 400 -99.96% | 40,0 841 -95.24% | 0,00 |
EBITDA Million JPY | Released Forecast Spread | -341 -417 18.28% | -1 162 435 -367.34% | -943 -1 030 8.4% | 0,00 |
EBIT Million JPY | Released Forecast Spread | -398 -420 5.24% | -1 239 1 501 -182.57% | -2 063 -1 160 -77.92% | -2 370 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -439 -463 5.18% | -745 603 -223.53% | -2 707 -1 150 -135.49% | -2 390 |
Net income Million JPY | Released Forecast Spread | -448 -467 3.97% | -738 558 -232.27% | -2 702 -1 142 -136.66% | -2 391 |
EPS JPY | Released Forecast Spread | -17,0 -17,1 0.47% | -25,7 19,6 -231.26% | -92,9 -32,7 -184.12% | -77,2 |
Announcement Date | 12/02/21 | 14/02/22 | 13/02/23 | 14/02/24 |
Quarterly results
Fiscal Period | December | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 1,10 0,00 - | 40,0 0,00 - | 0,00 0,00 - | 40,0 | 0,00 0,00 - | 0,00 800 - | 0,00 0,00 - | ||||
EBIT Million JPY | Released Forecast Spread | -477 -434 -9.98% | -466 -360 -29.44% | -402 -273 -47.37% | -868 | -570 -510 -11.76% | -625 279 -324.24% | -514 | -530 -546 2.85% | -1 044 | -565 | |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 20,9 -434 104.82% | -570 1 583 -136% | -443 -350 -26.57% | -780 | -534 | -532 | -1 032 | -548 | |||
Net income Million JPY | Released Forecast Spread | 17,7 -434 104.08% | -558 1 187 -146.97% | -438 -350 -25.14% | -775 | -534 | -532 | -1 033 | -548 | |||
EPS JPY | Released Forecast Spread | 0,62 | -19,4 -11,8 -63.68% | -15,1 -12,5 -20.85% | -11,6 -10,0 -15.58% | -26,7 | -18,3 -17,2 -6.57% | -47,8 12,4 -486.81% | -17,9 | -16,8 -10,1 -67.23% | -34,7 | -17,6 |
Announcement Date | 05/08/21 | 14/02/22 | 09/05/22 | 05/08/22 | 05/08/22 | 07/11/22 | 13/02/23 | 09/05/23 | 07/08/23 | 07/08/23 | 07/11/23 |
Past sector events for Modalis Therapeutics Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4883 Stock
- Calendar Modalis Therapeutics Corporation